GH
Price
$49.90
Change
-$0.09 (-0.18%)
Updated
Jun 25 closing price
Capitalization
2.46B
35 days until earnings call
TWST
Price
$37.25
Change
+$0.26 (+0.70%)
Updated
Jun 26, 11:54 AM (EDT)
Capitalization
1.98B
36 days until earnings call
Interact to see
Advertisement

GH vs TWST

Header iconGH vs TWST Comparison
Open Charts GH vs TWSTBanner chart's image
Guardant Health
Price$49.90
Change-$0.09 (-0.18%)
Volume$1.67M
Capitalization2.46B
Twist Bioscience
Price$37.25
Change+$0.26 (+0.70%)
Volume$200
Capitalization1.98B
GH vs TWST Comparison Chart in %
Loading...
GH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TWST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GH vs. TWST commentary
Jun 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GH is a Buy and TWST is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 26, 2025
Stock price -- (GH: $49.90 vs. TWST: $36.99)
Brand notoriety: GH: Notable vs. TWST: Not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: GH: 68% vs. TWST: 129%
Market capitalization -- GH: $2.46B vs. TWST: $1.98B
GH [@Medical Specialties] is valued at $2.46B. TWST’s [@Medical Specialties] market capitalization is $1.98B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GH’s FA Score shows that 0 FA rating(s) are green whileTWST’s FA Score has 0 green FA rating(s).

  • GH’s FA Score: 0 green, 5 red.
  • TWST’s FA Score: 0 green, 5 red.
According to our system of comparison, TWST is a better buy in the long-term than GH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GH’s TA Score shows that 5 TA indicator(s) are bullish while TWST’s TA Score has 6 bullish TA indicator(s).

  • GH’s TA Score: 5 bullish, 5 bearish.
  • TWST’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, TWST is a better buy in the short-term than GH.

Price Growth

GH (@Medical Specialties) experienced а -1.32% price change this week, while TWST (@Medical Specialties) price change was +3.06% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.79%. For the same industry, the average monthly price growth was +2.12%, and the average quarterly price growth was -0.19%.

Reported Earning Dates

GH is expected to report earnings on Jul 31, 2025.

TWST is expected to report earnings on Aug 01, 2025.

Industries' Descriptions

@Medical Specialties (+0.79% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GH($2.47B) has a higher market cap than TWST($1.98B). GH YTD gains are higher at: 63.339 vs. TWST (-20.400). TWST has higher annual earnings (EBITDA): -172.41M vs. GH (-433.3M). GH has more cash in the bank: 1.17B vs. TWST (311M). TWST has less debt than GH: TWST (91.9M) vs GH (1.35B). GH has higher revenues than TWST: GH (564M) vs TWST (262M).
GHTWSTGH / TWST
Capitalization2.47B1.98B124%
EBITDA-433.3M-172.41M251%
Gain YTD63.339-20.400-310%
P/E RatioN/AN/A-
Revenue564M262M215%
Total Cash1.17B311M376%
Total Debt1.35B91.9M1,473%
FUNDAMENTALS RATINGS
GH vs TWST: Fundamental Ratings
GH
TWST
OUTLOOK RATING
1..100
2317
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
44
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
3757
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TWST's Valuation (44) in the Biotechnology industry is in the same range as GH (67) in the Medical Or Nursing Services industry. This means that TWST’s stock grew similarly to GH’s over the last 12 months.

TWST's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as GH (100) in the Medical Or Nursing Services industry. This means that TWST’s stock grew similarly to GH’s over the last 12 months.

TWST's SMR Rating (97) in the Biotechnology industry is in the same range as GH (100) in the Medical Or Nursing Services industry. This means that TWST’s stock grew similarly to GH’s over the last 12 months.

GH's Price Growth Rating (37) in the Medical Or Nursing Services industry is in the same range as TWST (57) in the Biotechnology industry. This means that GH’s stock grew similarly to TWST’s over the last 12 months.

GH's P/E Growth Rating (100) in the Medical Or Nursing Services industry is in the same range as TWST (100) in the Biotechnology industry. This means that GH’s stock grew similarly to TWST’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GHTWST
RSI
ODDS (%)
Bearish Trend 1 day ago
79%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
89%
Momentum
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
84%
MACD
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 9 days ago
78%
Bullish Trend 1 day ago
79%
Declines
ODDS (%)
Bearish Trend 15 days ago
82%
Bearish Trend 14 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
63%
Bearish Trend 1 day ago
86%
Aroon
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
GH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TWST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HULIX33.37N/A
N/A
Huber Select Large Cap Value Inv
HRSMX73.11N/A
N/A
Hood River Small-Cap Growth Instl
BRXRX15.08N/A
N/A
MFS Blended Research Intl Eq R1
JIASX9.36N/A
N/A
JHancock Multi-Asset High Income R6
RFEBX85.36-0.13
-0.15%
American Funds Fundamental Invs R2E